Congenital Disorders of Glycosylation with Emphasis on Cerebellar Involvement

 

 Buy Article Permissions and Reprints

Abstract

Congenital disorders of glycosylation (CDG) are genetic diseases due to defective glycosylation of proteins and lipids. The authors present an update on these disorders affecting the central nervous system with a focus on cerebellar involvement. The rate of identification of novel CDG shows an exponential increase. Some 76 CDG are actually known, not taking into account the defects in glycan-modifying proteins. Neurologic involvement is present in the large majority of CDG. Screening methods are limited to serum transferrin isoelectrofocusing (for N-glycosylation disorders with sialic acid deficiency), and serum apolipoprotein C-III isoelectrofocusing (for core 1 mucin-type O-glycosylation disorders). Whole exome/genome sequencing is increasingly used in the diagnostic workup of patients with CDG-X. Treatment is greatly lagging behind because only one CDG is efficiently treatable (MPI-CDG). Cerebellar involvement is an important feature of PMM2-CDG, the congenital muscular dystrophies due to dystroglycanopathy, and SRD5A3-CDG. It has also been reported in some patients with ALG1-CDG, ALG3-CDG, ALG9-CDG, ALG6-CDG, ALG8-CDG, PIGA-CDG, DPM1-CDG, DPM2-CDG, B4GALT1-CDG, SLC35A2-CDG, COG1-CDG, COG5-CDG, COG7-CDG, and COG8-CDG.

Note

Rita Barone and Agata Fiumara contributed equally to the article.

• References

• 1 Freeze HH, Chong JX, Bamshad MJ, Ng BG. Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am J Hum Genet 2014; 94 (2) 161-175
  CrossrefPubMedGoogle Scholar
• 2 Krasnewich D. Human glycosylation disorders. Cancer Biomark 2014; 14 (1) 3-16
  PubMedGoogle Scholar
• 3 Wolthuis DF, Janssen MC, Cassiman D, Lefeber DJ, Morava E. Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylation. Expert Rev Mol Diagn 2014; 14 (2) 217-224
  CrossrefPubMedGoogle Scholar
• 4 Cylwik B, Naklicki M, Chrostek L, Gruszewska E. Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation. Acta Biochim Pol 2013; 60 (2) 151-161
  PubMedGoogle Scholar
• 5 Funke S, Gardeitchik T, Kouwenberg D , et al. Perinatal and early infantile symptoms in congenital disorders of glycosylation. Am J Med Genet A 2013; 161A (3) 578-584
  PubMedGoogle Scholar
• 6 Jaeken J. Congenital disorders of glycosylation. In: Dulac O, Lassonde M, Sarnat HB, , eds. Handbook of Clinical Neurology. Amsterdam: Elsevier; 2013: 1737-1743
  CrossrefGoogle Scholar
• 7 Matthijs G, Rymen D, Millón MB, Souche E, Race V. Approaches to homozygosity mapping and exome sequencing for the identification of novel types of CDG. Glycoconj J 2013; 30 (1) 67-76
  CrossrefPubMedGoogle Scholar
• 8 Rosnoblet C, Peanne R, Legrand D, Foulquier F. Glycosylation disorders of membrane trafficking. Glycoconj J 2013; 30 (1) 23-31
  CrossrefPubMedGoogle Scholar
• 9 Barone R, Sturiale L, Palmigiano A, Zappia M, Garozzo D. Glycomics of pediatric and adulthood diseases of the central nervous system. J Proteomics 2012; 75 (17) 5123-5139
  CrossrefPubMedGoogle Scholar
• 10 Goreta SS, Dabelic S, Dumic J. Insights into complexity of congenital disorders of glycosylation. Biochem Med (Zagreb) 2012; 22 (2) 156-170
  PubMedGoogle Scholar
• 11 Hennet T. Diseases of glycosylation beyond classical congenital disorders of glycosylation. Biochim Biophys Acta 2012; 1820 (9) 1306-1317
  CrossrefPubMedGoogle Scholar
• 12 Woods AG, Woods CW, Snow TM. Congenital disorders of glycosylation. Adv Neonatal Care 2012; 12 (2) 90-95
  CrossrefPubMedGoogle Scholar
• 13 Rymen D, Jaeken J. Skin manifestations in CDG. J Inherit Metab Dis 2014; ; Epub ahead of print
  PubMedGoogle Scholar
• 14 Freeze HH, Eklund EA, Ng BG, Patterson MC. Neurology of inherited glycosylation disorders. Lancet Neurol 2012; 11 (5) 453-466
  CrossrefPubMedGoogle Scholar
• 15 Footitt EJ, Karimova A, Burch M , et al. Cardiomyopathy in the congenital disorders of glycosylation (CDG): a case of late presentation and literature review. J Inherit Metab Dis 2009; 32 (Suppl. 01) S313-S319
  CrossrefPubMedGoogle Scholar
• 16 Morava E, Wosik HN, Sykut-Cegielska J , et al. Ophthalmological abnormalities in children with congenital disorders of glycosylation type I. Br J Ophthalmol 2009; 93 (3) 350-354
  CrossrefPubMedGoogle Scholar
• 17 Coman D, Irving M, Kannu P, Jaeken J, Savarirayan R. The skeletal manifestations of the congenital disorders of glycosylation. Clin Genet 2008; 73 (6) 507-515
  CrossrefPubMedGoogle Scholar
• 18 Basmanav FB, Oprisoreanu AM, Pasternack SM , et al. Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease. Am J Hum Genet 2014; 94 (1) 135-143
  CrossrefPubMedGoogle Scholar
• 19 Zhang Y, Yu X, Ichikawa M , et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol 2014; 133 (5) 1400-1409 , e1–e5
  CrossrefPubMedGoogle Scholar
• 20 Tegtmeyer LC, Rust S, van Scherpenzeel M , et al. Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med 2014; 370 (6) 533-542
  CrossrefPubMedGoogle Scholar
• 21 Timal S, Hoischen A, Lehle L , et al. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. Hum Mol Genet 2012; 21 (19) 4151-4161
  CrossrefPubMedGoogle Scholar
• 22 Pérez B, Medrano C, Ecay MJ , et al. A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene. J Inherit Metab Dis 2013; 36 (3) 535-542
  CrossrefPubMedGoogle Scholar
• 23 Mohamed M, Cantagrel V, Al-Gazali L, Wevers RA, Lefeber DJ, Morava E. Normal glycosylation screening does not rule out SRD5A3-CDG. Eur J Hum Genet 2011; 19 (10) 1019
  CrossrefPubMedGoogle Scholar
• 24 Lefeber DJ, Morava E, Jaeken J. How to find and diagnose a CDG due to defective N-glycosylation. J Inherit Metab Dis 2011; 34 (4) 849-852
  CrossrefPubMedGoogle Scholar
• 25 van Scherpenzeel M, Timal S, Rymen D , et al. Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency. Brain 2014; 137 (Pt 4) 1030-1038
  CrossrefPubMedGoogle Scholar
• 26 Rymen D, Peanne R, Millón MB , et al. MAN1B1 deficiency: an unexpected CDG-II. PLoS Genet 2013; 9 (12) e1003989
  CrossrefPubMedGoogle Scholar
• 27 de Lonlay P, Seta N. The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. Biochim Biophys Acta 2009; 1792 (9) 841-843
  CrossrefPubMedGoogle Scholar
• 28 Helander A, Jaeken J, Matthijs G, Eggertsen G. Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption. Clin Chim Acta 2014; 431: 15-18
  CrossrefPubMedGoogle Scholar
• 29 Bönnemann CG, Wang CH, Quijano-Roy S , et al; Members of International Standard of Care Committee for Congenital Muscular Dystrophies. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord 2014; 24 (4) 289-311
  CrossrefPubMedGoogle Scholar
• 30 Swoboda KJ, Margraf RL, Carey JC , et al. A novel germline PIGA mutation in ferro-cerebro-cutaneous syndrome: a neurodegenerative X-linked epileptic encephalopathy with systemic iron-overload. Am J Med Genet A 2014; 164A (1) 17-28
  PubMedGoogle Scholar
• 31 Dauber A, Ercan A, Lee J , et al. Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect. Hum Mol Genet 2014; 23 (11) 2880-2887
  CrossrefPubMedGoogle Scholar
• 32 Ferris SP, Kodali VK, Kaufman RJ. Glycoprotein folding and quality-control mechanisms in protein-folding diseases. Dis Model Mech 2014; 7 (3) 331-341
  CrossrefPubMedGoogle Scholar
• 33 Grünewald S. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim Biophys Acta 2009; 1792 (9) 827-834
  CrossrefPubMedGoogle Scholar
• 34 Drouin-Garraud V, Belgrand M, Grünewald S , et al. Neurological presentation of a congenital disorder of glycosylation CDG-Ia: implications for diagnosis and genetic counseling. Am J Med Genet 2001; 101 (1) 46-49
  CrossrefPubMedGoogle Scholar
• 35 Schoffer KL, O'Sullivan JD, McGill J. Congenital disorder of glycosylation type Ia presenting as early-onset cerebellar ataxia in an adult. Mov Disord 2006; 21 (6) 869-872
  CrossrefPubMedGoogle Scholar
• 36 Vermeer S, Kremer HP, Leijten QH , et al. Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening. J Neurol 2007; 254 (10) 1356-1358
  CrossrefPubMedGoogle Scholar
• 37 Stark KL, Gibson JB, Hertle RW, Brodsky MC. Ocular motor signs in an infant with carbohydrate-deficient glycoprotein syndrome type Ia. Am J Ophthalmol 2000; 130 (4) 533-535
  CrossrefPubMedGoogle Scholar
• 38 Coorg R, Lotze TE. Child Neurology: a case of PMM2-CDG (CDG 1a) presenting with unusual eye movements. Neurology 2012; 79 (15) e131-e133
  CrossrefPubMedGoogle Scholar
• 39 Melberg A, Orlén H, Raininko R , et al. Re-evaluation of the dysequilibrium syndrome. Acta Neurol Scand 2011; 123 (1) 28-33
  PubMedGoogle Scholar
• 40 Lecca MR, Wagner U, Patrignani A, Berger EG, Hennet T. Genome-wide analysis of the unfolded protein response in fibroblasts from congenital disorders of glycosylation type-I patients. FASEB J 2005; 19 (2) 240-242
  PubMedGoogle Scholar
• 41 Sun L, Zhao Y, Zhou K, Freeze HH, Zhang YW, Xu H. Insufficient ER-stress response causes selective mouse cerebellar granule cell degeneration resembling that seen in congenital disorders of glycosylation. Mol Brain 2013; 6: 52-60
  CrossrefPubMedGoogle Scholar
• 42 Jaeken J, Vanderschueren-Lodeweyckx M, Casaer M , et al. Familial psychomotor retardation with markedly fluctuating serum proteins, FSH and GH levels, partial TBG deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome?. Pediatr Res 1980; 14: 179
  PubMedGoogle Scholar
• 43 Akaboshi S, Ohno K, Takeshita K. Neuroradiological findings in the carbohydrate-deficient glycoprotein syndrome. Neuroradiology 1995; 37 (6) 491-495
  CrossrefPubMedGoogle Scholar
• 44 Horslen SP, Clayton PT, Harding BN, Hall NA, Keir G, Winchester B. Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome. Arch Dis Child 1991; 66 (9) 1027-1032
  CrossrefPubMedGoogle Scholar
• 45 Holzbach U, Hanefeld F, Helms G, Hänicke W, Frahm J. Localized proton magnetic resonance spectroscopy of cerebral abnormalities in children with carbohydrate-deficient glycoprotein syndrome. Acta Paediatr 1995; 84 (7) 781-786
  CrossrefPubMedGoogle Scholar
• 46 Pavone L, Fiumara A, Barone R , et al. Olivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome type I. J Neurol 1996; 243 (10) 700-705
  CrossrefPubMedGoogle Scholar
• 47 Miossec-Chauvet E, Mikaeloff Y, Heron D , et al. Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia. Neuropediatrics 2003; 34 (1) 1-6
  Article in Thieme ConnectPubMedGoogle Scholar
• 48 Coman D, McGill J, MacDonald R , et al. Congenital disorder of glycosylation type 1a: three siblings with a mild neurological phenotype. J Clin Neurosci 2007; 14 (7) 668-672
  CrossrefPubMedGoogle Scholar
• 49 Shanti B, Silink M, Bhattacharya K , et al. Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency. J Inherit Metab Dis 2009; 32 (Suppl. 01) S241-S251
  CrossrefPubMedGoogle Scholar
• 50 Antoun H, Villeneuve N, Gelot A, Panisset S, Adamsbaum C. Cerebellar atrophy: an important feature of carbohydrate deficient glycoprotein syndrome type 1. Pediatr Radiol 1999; 29 (3) 194-198
  CrossrefPubMedGoogle Scholar
• 51 Agamanolis DP, Potter JL, Naito HK, Robinson Jr HB, Kulasekaran T. Lipoprotein disorder, cirrhosis, and olivopontocerebellar degeneration in two siblings. Neurology 1986; 36 (5) 674-681
  CrossrefPubMedGoogle Scholar
• 52 Harding BN, Dunger DB, Grant DB, Erdohazi M. Familial olivopontocerebellar atrophy with neonatal onset: a recessively inherited syndrome with systemic and biochemical abnormalities. J Neurol Neurosurg Psychiatry 1988; 51 (3) 385-390
  CrossrefPubMedGoogle Scholar
• 53 Fiumara A, Barone R, Nigro F, Sorge G, Pavone L. Familial Dandy-Walker variant in CDG syndrome. Am J Med Genet 1996; 63 (2) 412-413
  CrossrefPubMedGoogle Scholar
• 54 Barkovich AJ, Millen KJ, Dobyns WB. A developmental classification of malformations of the brainstem. Ann Neurol 2007; 62 (6) 625-639
  CrossrefPubMedGoogle Scholar
• 55 Di Rocco M. On Saraiva and Baraitser and Joubert syndrome: a review. Am J Med Genet 1993; 46 (6) 732-733
  CrossrefPubMedGoogle Scholar
• 56 Morava E, Cser B, Kárteszi J , et al. Screening for CDG type Ia in Joubert syndrome. Med Sci Monit 2004; 10 (8) CR469-CR472
  PubMedGoogle Scholar
• 57 Romani M, Micalizzi A, Valente EM. Joubert syndrome: congenital cerebellar ataxia with the molar tooth. Lancet Neurol 2013; 12 (9) 894-905
  CrossrefPubMedGoogle Scholar
• 58 Feraco P, Mirabelli-Badenier M, Severino M , et al. The shrunken, bright cerebellum: a characteristic MRI finding in congenital disorders of glycosylation type 1a. AJNR Am J Neuroradiol 2012; 33 (11) 2062-2067
  CrossrefPubMedGoogle Scholar
• 59 Poretti A, Wolf NI, Boltshauser E. Differential diagnosis of cerebellar atrophy in childhood. Eur J Paediatr Neurol 2008; 12 (3) 155-167
  CrossrefPubMedGoogle Scholar
• 60 Vedolin L, Gonzalez G, Souza CF, Lourenço C, Barkovich AJ. Inherited cerebellar ataxia in childhood: a pattern-recognition approach using brain MRI. AJNR Am J Neuroradiol 2013; 34 (5) 925-934 , S1–S2
  CrossrefPubMedGoogle Scholar
• 61 Jensen PR, Hansen FJ, Skovby F. Cerebellar hypoplasia in children with the carbohydrate-deficient glycoprotein syndrome. Neuroradiology 1995; 37 (4) 328-330
  CrossrefPubMedGoogle Scholar
• 62 Enns GM, Steiner RD, Buist N , et al. Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins. J Pediatr 2002; 141 (5) 695-700
  CrossrefPubMedGoogle Scholar
• 63 Mader I, Döbler-Neumann M, Küker W, Stibler H, Krägeloh-Mann I. Congenital disorder of glycosylation type Ia: benign clinical course in a new genetic variant. Childs Nerv Syst 2002; 18 (1-2) 77-80
  CrossrefPubMedGoogle Scholar
• 64 Kjaergaard S, Schwartz M, Skovby F. Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype. Arch Dis Child 2001; 85 (3) 236-239
  CrossrefPubMedGoogle Scholar
• 65 Worthington S, Arbuckle S, Nelson P, Carey W, Lipson A, Fagan E. Carbohydrate deficient glycoprotein syndrome type I: a cause of cerebellar vermis hypoplasia. J Paediatr Child Health 1997; 33 (6) 531-534
  CrossrefPubMedGoogle Scholar
• 66 Aronica E, van Kempen AA, van der Heide M , et al. Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology. Acta Neuropathol 2005; 109 (4) 433-442
  CrossrefPubMedGoogle Scholar
• 67 Strømme P, Maehlen J, Strømme H, Torvik A. Postmortem findings in two patients with the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand 1991; 375: 55-62
  PubMedGoogle Scholar
• 68 Pérez-Dueñas B, García-Cazorla A, Pineda M , et al. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations. Eur J Paediatr Neurol 2009; 13 (5) 444-451
  CrossrefPubMedGoogle Scholar
• 69 Mercuri E, Muntoni F. The ever-expanding spectrum of congenital muscular dystrophies. Ann Neurol 2012; 72 (1) 9-17
  CrossrefPubMedGoogle Scholar
• 70 Godfrey C, Clement E, Mein R , et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007; 130 (Pt 10) 2725-2735
  CrossrefPubMedGoogle Scholar
• 71 Lommel M, Winterhalter PR, Willer T , et al. Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. Proc Natl Acad Sci U S A 2013; 110 (52) 21024-21029
  CrossrefPubMedGoogle Scholar
• 72 Vester-Christensen MB, Halim A, Joshi HJ , et al. Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins. Proc Natl Acad Sci U S A 2013; 110 (52) 21018-21023
  CrossrefPubMedGoogle Scholar
• 73 Cantagrel V, Lefeber DJ, Ng BG , et al. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell 2010; 142 (2) 203-217
  CrossrefPubMedGoogle Scholar
• 74 Al-Gazali L, Hertecant J, Algawi K, El Teraifi H, Dattani M. A new autosomal recessive syndrome of ocular colobomas, ichthyosis, brain malformations and endocrine abnormalities in an inbred Emirati family. Am J Med Genet A 2008; 146 (7) 813-819
  PubMedGoogle Scholar
• 75 Morava E, Wevers RA, Cantagrel V , et al. A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism. Brain 2010; 133 (11) 3210-3220
  CrossrefPubMedGoogle Scholar
• 76 Kahrizi K, Hu CH, Garshasbi M , et al. Next generation sequencing in a family with autosomal recessive Kahrizi syndrome (OMIM 612713) reveals a homozygous frameshift mutation in SRD5A3. Eur J Hum Genet 2011; 19 (1) 115-117
  CrossrefPubMedGoogle Scholar
• 77 Gründahl JE, Guan Z, Rust S , et al. Life with too much polyprenol: polyprenol reductase deficiency. Mol Genet Metab 2012; 105 (4) 642-651
  CrossrefPubMedGoogle Scholar
• 78 Kasapkara CS, Tümer L, Ezgü FS , et al. SRD5A3-CDG: a patient with a novel mutation. Eur J Paediatr Neurol 2012; 16 (5) 554-556
  CrossrefPubMedGoogle Scholar
• 79 Kara B, Ayhan Ö, Gökçay G, Başboğaoğlu N, Tolun A. Adult phenotype and further phenotypic variability in SRD5A3-CDG. BMC Med Genet 2014; 15: 10
  PubMedGoogle Scholar
• 80 Dupré T, Vuillaumier-Barrot S, Chantret I , et al. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations. J Med Genet 2010; 47 (11) 729-735
  CrossrefPubMedGoogle Scholar
• 81 Morava E, Vodopiutz J, Lefeber DJ , et al. Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations. Pediatrics 2012; 130 (4) e1034-e1039
  CrossrefPubMedGoogle Scholar
• 82 Kranz C, Sun L, Eklund EA, Krasnewich D, Casey JR, Freeze HH. CDG-Id in two siblings with partially different phenotypes. Am J Med Genet A 2007; 143A (13) 1414-1420
  CrossrefPubMedGoogle Scholar
• 83 Rimella-Le-Huu A, Henry H, Kern I , et al. Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient. J Inherit Metab Dis 2008; 31 (Suppl. 02) S381-S386
  CrossrefPubMedGoogle Scholar
• 84 Weinstein M, Schollen E, Matthijs G , et al. CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features. Am J Med Genet A 2005; 136 (2) 194-197
  PubMedGoogle Scholar
• 85 Dercksen M, Crutchley AC, Honey EM , et al. ALG6-CDG in South Africa: genotype-phenotype description of five novel patients. JIMD Rep 2013; 8: 17-23
  PubMedGoogle Scholar
• 86 Ichikawa K, Kadoya M, Wada Y, Okamoto N. Congenital disorder of glycosylation type Ic: report of a Japanese case. Brain Dev 2013; 35 (6) 586-589
  CrossrefPubMedGoogle Scholar
• 87 Vesela K, Honzik T, Hansikova H , et al. A new case of ALG8 deficiency (CDG Ih). J Inherit Metab Dis 2009; 32 (Suppl. 01) 259-264
  CrossrefPubMedGoogle Scholar
• 88 Sorte H, Mørkrid L, Rødningen O , et al. Severe ALG8-CDG (CDG-Ih) associated with homozygosity for two novel missense mutations detected by exome sequencing of candidate genes. Eur J Med Genet 2012; 55 (3) 196-202
  CrossrefPubMedGoogle Scholar
• 89 Johnston JJ, Gropman AL, Sapp JC , et al. The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria. Am J Hum Genet 2012; 90 (2) 295-300
  CrossrefPubMedGoogle Scholar
• 90 Yang AC, Ng BG, Moore SA , et al. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy. Mol Genet Metab 2013; 110 (3) 345-351
  CrossrefPubMedGoogle Scholar
• 91 Kim S, Westphal V, Srikrishna G , et al. Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie). J Clin Invest 2000; 105 (2) 191-198
  CrossrefPubMedGoogle Scholar
• 92 Dancourt J, Vuillaumier-Barrot S, de Baulny HO , et al. A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings. Pediatr Res 2006; 59 (6) 835-839
  CrossrefPubMedGoogle Scholar
• 93 Barone R, Aiello C, Race V , et al. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy. Ann Neurol 2012; 72 (4) 550-558
  CrossrefPubMedGoogle Scholar
• 94 Peters V, Penzien JM, Reiter G , et al. Congenital disorder of glycosylation IId (CDG-IId) — a new entity: clinical presentation with Dandy-Walker malformation and myopathy. Neuropediatrics 2002; 33 (1) 27-32
  Article in Thieme ConnectPubMedGoogle Scholar
• 95 Ng BG, Buckingham KJ, Raymond K , et al; University of Washington Center for Mendelian Genomics. Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation. Am J Hum Genet 2013; 92 (4) 632-636
  CrossrefPubMedGoogle Scholar
• 96 Kodera H, Nakamura K, Osaka H , et al. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy. Hum Mutat 2013; 34 (12) 1708-1714
  CrossrefPubMedGoogle Scholar
• 97 Foulquier F, Vasile E, Schollen E , et al. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. Proc Natl Acad Sci U S A 2006; 103 (10) 3764-3769
  CrossrefPubMedGoogle Scholar
• 98 Zeevaert R, Foulquier F, Dimitrov B , et al. Cerebrocostomandibular-like syndrome and a mutation in the conserved oligomeric Golgi complex, subunit 1. Hum Mol Genet 2009; 18 (3) 517-524
  PubMedGoogle Scholar
• 99 Rymen D, Keldermans L, Race V , et al. COG5-CDG: expanding the clinical spectrum. Orphanet J Rare Dis 2012; 7: 94-104
  CrossrefPubMedGoogle Scholar
• 100 Zeevaert R, Foulquier F, Cheillan D , et al. A new mutation in COG7 extends the spectrum of COG subunit deficiencies. Eur J Med Genet 2009; 52 (5) 303-305
  CrossrefPubMedGoogle Scholar
• 101 Foulquier F, Ungar D, Reynders E , et al. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation. Hum Mol Genet 2007; 16 (7) 717-730
  CrossrefPubMedGoogle Scholar
• 102 Boddaert N, Desguerre I, Bahi-Buisson N , et al. Posterior fossa imaging in 158 children with ataxia. J Neuroradiol 2010; 37 (4) 220-230
  CrossrefPubMedGoogle Scholar